Cellectis (CLLS) Receivables - Net (2013 - 2026)
Cellectis' (CLLS) quarterly Receivables - Net came in at $5.2 million in Q1 2026, down 34.55% year-on-year from $7.9 million in Q1 2025, and down 64.22% quarter-over-quarter from $14.4 million in Q4 2025.
Cellectis (CLLS) Receivables - Net (2013 - 2026) Analysis & Trends
Cellectis' Receivables - Net history runs 14 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 34.55% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 34.55% decrease from a year earlier, with the FY2025 full-year figure at $14.4 million, up 114.45% from the prior year.
- Receivables - Net slipped to $5.2 million in Q1 2026 per CLLS's latest filing, from $14.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $21.8 million in Q1 2022 and bottomed at $393000.0 in Q3 2023.
- The 5-year median for Receivables - Net is $6.7 million (2024), against an average of $6.8 million.
- Across the five-year window, Receivables - Net tumbled 96.21% in 2022 and jumped 2744.78% in 2024, its largest moves.
- Year by year, Receivables - Net stood at $772000.0 in 2022, then retreated by 26.3% to $569000.0 in 2023, then soared by 1079.96% to $6.7 million in 2024, then soared by 114.45% to $14.4 million in 2025, then plunged by 64.22% to $5.2 million in 2026.
- Per Business Quant, the three latest CLLS Receivables - Net figures stand at $5.2 million (Q1 2026), $14.4 million (Q4 2025), and $8.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Jun 30, 2025 | 8.78 Mn |
| Jun 30, 2025 | 8.78 Mn |
| Mar 31, 2025 | 7.87 Mn |
| Mar 31, 2025 | 7.87 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 11.18 Mn |
| Sep 30, 2024 | 11.18 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 16.04 Mn |
| Mar 31, 2024 | 16.04 Mn |
| Dec 31, 2023 | 569,000.00 |
| Dec 31, 2023 | 569,000.00 |